Aug 9 (Reuters) - Cardiome Pharma Corp COM.TO
* Q2 revenue $5.9 million versus i/b/e/s view $6.8 million
* Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S
* Cardiome reports second quarter 2016 financial results
* Q2 loss per share $0.37
* Cardiome pharma corp says gross margin decreased to 71.4% and 76.1% for three and six months ended june 30, 2016, respectively Source text for Eikon: ID:nCNW75hTPa Further company coverage: COM.TO